Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Development-stage index

Phase 4Peptide Trials.

Explore every Phase 4 peptide study in the local registry snapshot. Compare recruitment, sponsors, therapeutic areas, enrollment, results, publications and study geography.

Studies
373
Recruiting
42
Completed
169
Results posted
82
Countries
60
Avg enrollment
300

Velocity

Phase 4 trials by start year

Study start year · indexed snapshot

3023158020002000: 1 trials2001: 0 trials2002: 0 trials2003: 2 trials2004: 7 trials20052005: 9 trials2006: 8 trials2007: 8 trials2008: 5 trials2009: 11 trials20102010: 5 trials2011: 7 trials2012: 14 trials2013: 10 trials2014: 22 trials20152015: 17 trials2016: 18 trials2017: 15 trials2018: 28 trials2019: 29 trials20202020: 20 trials2021: 17 trials2022: 18 trials2023: 22 trials2024: 25 trials20252025: 24 trials2026: 30 trials20272027: 1 trials

Development

Trials by phase

Early Phase 10
Phase 10
Phase 20
Phase 30
Phase 4373

Industry

Leading sponsors

Hoffmann-La Roche10
Eli Lilly6
GlaxoSmithKline5
Ipsen5
Sanofi5
Novartis4
AstraZeneca3
Novo Nordisk3

Therapeutic areas

Condition groups

Weight loss39
Type 2 diabetes36
Pain7
Brain health6
Longevity5
Inflammation4
Crohn's1

Compound leaders

Most represented peptides.

01Bivalirudin3202Carbetocin2303Liraglutide2304Teriparatide2005Cetrorelix1906Lixisenatide1907Desmopressin1808Dulaglutide1709Ganirelix1710Enfuvirtide1511Calcitonin1212Vasopressin12

Study explorer

Search this collection.

373 matching studies